E
eXoZymes, Inc. EXOZ
$10.76 -$0.095-0.88% NASDAQ
Recommendation
Prev Close
$10.85
Volume
2,503
Avg Vol (90D)
19,800
Market Cap
$90.79M
Dividend & Yield
--
52-Week Range
$8.50 - $23.99
P/E (TTM)
--
EPS (TTM)
-$0.8887
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bringing clarity and precision to the cell-free space by introducing exozymes
4/21/2025 - Globe Newswire
BioClick -- an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K ...
4/10/2025 - GuruFocus
BioClick -- an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K ...
4/10/2025 - GuruFocus
BioClick an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
4/10/2025 - Globe Newswire
MDB Capital Holdings, LLC Class A common (NASDAQ:MDBH) Q4 2024 Earnings Call Transcript
4/5/2025 - Insider Monkey
MDB Capital Holdings, LLC Class A common (NASDAQ:MDBH) Q4 2024 Earnings Call Transcript
4/5/2025 - Insider Monkey
eXoZymes Inc. Reports 2024 Progress and IPO Success
4/3/2025 - TipRanks Financial Blog
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
4/2/2025 - GuruFocus
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
4/2/2025 - GuruFocus
eXoZymes appoints Damien Perriman chief commercial officer
4/2/2025 - The Fly
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
4/2/2025 - Globe Newswire
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
4/2/2025 - Globe Newswire
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April ...
3/26/2025 - GuruFocus
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
3/26/2025 - Globe Newswire
eXoZymes Inc trading resumes
3/17/2025 - TipRanks Financial Blog
eXoZymes Inc trading resumes
3/17/2025 - The Fly
eXoZymes Inc trading halted, volatility trading pause
3/17/2025 - TipRanks Financial Blog
eXoZymes Inc trading halted, volatility trading pause
3/17/2025 - The Fly
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
2/21/2025 - GuruFocus
eXoZymes president, chairman Hayat transitions out of roles
2/21/2025 - TipRanks Financial Blog
eXoZymes president, chairman Hayat transitions out of roles
2/21/2025 - The Fly
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
2/21/2025 - Globe Newswire
eXoZymes Inc trading resumes
2/19/2025 - TipRanks Financial Blog
eXoZymes Inc trading resumes
2/19/2025 - The Fly
eXoZymes Inc trading halted, volatility trading pause
2/19/2025 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$5.66M
EBIT (TTM)
-$5.93M
Net Income (TTM)
-$5.86M
Balance Sheet
Total Assets (Q)
$13.03M
Total Debt (Q)
$1.39M
Total Liabilities (Q)
$2.61M
Book Value Per Share (Q)
$1.25
Cash Flow
Cash from Operations (TTM)
-$8.51M
Cash from Investing (TTM)
-$359.10K
Cash from Financing (TTM)
$18.52M
Net Change in Cash (TTM)
$9.65M
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 19 and 23 (est)
Price History
Loading...
Beta
--
7-Day Total Return
0.23%
30-Day Total Return
-17.96%
60-Day Total Return
-33.07%
90-Day Total Return
-44.45%
Year to Date Total Return
-27.38%
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Nov 13, 2024 - $8.50
52-week High
Feb 13, 2025 - $23.99
Valuation
Market Cap
$90.79M - Micro Cap
Enterprise Value
$82.46M
Price/Sales (TTM)
--
Price/Book (Q)
8.71
Dividends and Shares
Shares Outstanding
7.50M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.exozymes.com
Phone Number
626 415 1488
Address
750 Royal Oaks Drive
Monrovia, CA 91016
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
eXoZymes, Inc. a development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes... more
NASDAQ 05/06/2025 12:06PM Eastern Quotes delayed